EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Wed, 18.12.2024
Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
18.12.2024 / 15:36 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude...
Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
08.10.2024 / 12:05 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to concl...
MPH Health Care AG: Preliminary IFRS result for the first half of 2024
EBIT increases significantly to 75.7 million euros. Equity (net asset value) increases by EUR 74.5 million to EUR 325.5 million, which corresponds to EUR 76.02 per share. The equity ratio rises to 94.7%.
Berlin, 5. September 2024 - MPH Health Care AG (ISIN: DE000A289V03) annou...
Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
Classification of First Berlin Equity Research GmbH to MPH Health Care AG
Company Name: MPH Health Care AG
ISIN: DE000A289V03
Reason for the research: Q1 & 2023 Ergebnisse
Recommendation: Kaufen
from: 12.06.2024
Target price: €113
Target price on sight of: 12 Monate...
MPH Health Care AG: Q1-results 2024
Strong increase in earnings due to positive development of investments. Equity (net asset value) increases significantly to EUR 251.6 million. This corresponds to EUR 58.77 per share (prior-year quarter Q1/2023: EUR 43.91). The equity ratio rises to 94.3%.
Berlin, 11 June 2024 - MPH Health Care AG (ISIN: DE000...
MPH Health Care AG: Q1-results 2024
Strong increase in earnings due to positive development of investments. Equity (net asset value) increases significantly to EUR 251.6 million. This corresponds to EUR 58.77 per share (prior-year quarter Q1/2023: EUR 43.91). The equity ratio rises to 94.3%.
Berlin, 11 June 2024 - MPH Health Care AG (ISIN: DE000...
Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
Classification of First Berlin Equity Research GmbH to MPH Health Care AG
Company Name: MPH Health Care AG
ISIN: DE000A289V03
Reason for the research: Vorläufige Ergebnisse 2023
Recommendation: Kaufen
from: 10.05.2024
Target price: €81
Target price on sight of: 12 Monat...
MPH Health Care AG: Supervisory Board adopts the 2023 annual financial statements. Dividend proposal of EUR 1.20 per share
Berlin, 07.05.2024 - At its balance sheet meeting today, the Supervisory Board of MPH Health Care AG (ISIN: DE000A289V03) approved the annual financial statements and the consolidated financial statements of the company for th...
MPH Health Care AG: Preliminary IFRS result 2023
Equity (net asset value) increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT increases to 30.2 million euros. The equity ratio rises to 94.2%.
Berlin, 25 April 2024 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS con...
On February 2, 2024, MPH Health Care AG successfully sold 1.5 million shares in its investment M1 Kliniken AG to the two members of the management board of M1 Kliniken AG, Mr. Attila Strauss and Mr. Kilian Brenske. The two Co-CEOs acquired the share package in order to strengthen their entrepreneurial commitment. The transaction underlines the mana...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .